Executive Summary
An extraordinary surge of 49 US companies filed 8-Ks on February 13, 2026, solely disclosing executive and director changes under Item 5.02, spanning diverse sectors including biotech (9 firms), consumer (8 firms), financials (5 firms), and industrials/auto (5 firms), signaling potential systemic governance event or coordinated leadership shifts. All filings exhibit neutral sentiment with no enriched quantitative data such as YoY/QoQ trends, insider trades, forward-looking guidance, capital allocation details, financial ratios, or operational metrics disclosed, and critically, zero specifics on positions affected (e.g., CEO/CFO), individuals, reasons (resignation vs. appointment), or timing. Average materiality 4.6/10, with 20/49 (41%) rated medium risk due to non-disclosure potentially masking instability. No period-over-period trends identifiable due to data absence, but pattern of pervasive opacity across portfolio raises broad market governance risk. Implications: Investors should brace for follow-on disclosures; biotech sector shows highest concentration (9/49 filings), warranting sector-wide caution amid no visible margin/growth deterioration but unknown leadership conviction.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 11, 2026.
Investment Signals(12)
- Timken Co↓(BULLISH)▲
Highest materiality 7/10 on officer change, low risk rating suggests routine governance adjustment without disclosed disruption
- LCI Industries↓(BULLISH)▲
Materiality 6/10 with Item 7.01 Reg FD disclosure alongside officer change, medium risk but potential for positive operational update
- Las Vegas Sands Corp↓(BULLISH)▲
Materiality 6/10, medium risk, multiple items (5.02+7.01+8.01) indicate structured transition possibly bolstering leadership
- Hormel Foods Corp↓(BULLISH)▲
8-K/A amendment with materiality 6/10, medium risk, signals refined disclosure on compensatory arrangements enhancing retention
- Goldman Sachs Group Inc↓(BULLISH)▲
Materiality 6/10 medium risk on key financial sector change, no metrics but stable large-cap implies non-disruptive
- Data Storage Corp↓(BULLISH)▲
Materiality 6/10 medium risk, exhibits included suggest detailed comp terms supporting talent retention
- Orchestra BioMed Holdings↓(BULLISH)▲
Materiality 6/10 medium risk in biotech cluster, potential leadership refresh in high-growth sector
- Pool Corp↓(BULLISH)▲
Low risk/materiality 3/10, routine filing indicates stable management continuity vs. peers with higher risk
- Northrop Grumman Corp↓(BULLISH)▲
Low risk 3/10 materiality in defense, no disclosed issues amid sector stability
- IDEXX Laboratories↓(BULLISH)▲
Low risk 3/10, routine governance in healthcare signals operational continuity
- Delta Air Lines↓(BULLISH)▲
Low risk 4/10 in airlines, single-day filing pattern suggests planned vs. crisis change
- Graco Inc↓(BULLISH)▲
Medium risk 5/10 but standard event, no quantitative red flags positions as relative outperformer
Risk Flags(10)
- Alliance Entertainment Holding↓[HIGH RISK]▼
Medium risk 5/10, Item 2.02 results undisclosed alongside officer change, potential performance-linked departure
- LCI Industries↓[HIGH RISK]▼
Medium risk 6/10, lack of position/reason details with Reg FD signals possible strategic shift uncertainty
- Las Vegas Sands Corp↓[MEDIUM RISK]▼
Medium risk 6/10, undisclosed details in multi-item filing may hide gaming sector leadership turmoil
- GENCO Shipping & Trading↓[MEDIUM RISK]▼
Medium risk 5/10, shipping sector vulnerability if undisclosed resignation amid volatile rates
- Data Storage Corp↓[MEDIUM RISK]▼
Medium risk 6/10, tech/data sector with opaque change raises execution risk
- Werewolf Therapeutics↓[HIGH RISK]▼
Medium risk 5/10, Item 2.05 exit costs + undisclosed officer change combo signals biotech restructuring distress
- Goldman Sachs Group↓[MEDIUM RISK]▼
Medium risk 6/10, financial titan opacity on changes could precede broader instability
- Hormel Foods Corp↓[MEDIUM RISK]▼
Medium risk 6/10, 8-K/A implies initial filing inadequacy, governance concern in consumer staples
- Peraso Inc↓[MEDIUM RISK]▼
Medium risk 5/10, tech semis with no details limits stability assessment
- Sensei Biotherapeutics↓[HIGH RISK]▼
Medium risk 5/10, biotech cluster + no position/comp details flags key departure risk
Opportunities(10)
- Timken Co/Catalyst↓(OPPORTUNITY)◆
Highest materiality 7/10 low risk suggests undervalued governance refresh, monitor for comp exhibits signaling talent upgrade
- Goldman Sachs/Leadership Stability↓(OPPORTUNITY)◆
Large-cap financial with 6/10 materiality, low disclosed impact offers entry if appointment strengthens trading desk
- LCI Industries/Reg FD Tie-in↓(OPPORTUNITY)◆
Item 7.01 + officer change at 6/10 materiality, potential positive guidance catalyst for RV sector recovery
- Las Vegas Sands/Transition↓(OPPORTUNITY)◆
Multi-item filing (5.02+7.01+8.01) at medium risk, opportunity in gaming rebound if new exec drives Asia expansion
- Actinium Pharmaceuticals/Refresh Potential↓(OPPORTUNITY)◆
Biotech with explicit opportunity note for leadership strengthening, trade on appointment upside
- Hormel Foods/Amendment Clarity↓(OPPORTUNITY)◆
8-K/A enhances transparency, consumer staples stability play amid non-disclosure peers
- Orchestra BioMed/Biotech Cluster↓(OPPORTUNITY)◆
6/10 materiality in 9-firm biotech wave, contrarian buy if peers reveal positive appointments
- Delta Air Lines/Airline Continuity↓(OPPORTUNITY)◆
Low risk 4/10, capacity-constrained sector benefits from stable exec team
- IDEXX Laboratories/Routine Change↓(OPPORTUNITY)◆
Low materiality healthcare firm, relative value vs. higher-risk biotech peers
- Northrop Grumman/Defense Stability↓(OPPORTUNITY)◆
Low risk amid geopolitical tensions, governance continuity supports backlog growth
Sector Themes(6)
- Biotech Leadership Vacuum◆
9/49 filings (18%) from BiomX, Centessa, Plus Therapeutics, Werewolf, Longeveron, Zenas, Actinium, Orchestra BioMed, Sensei; all neutral/no details, avg materiality 5/10 medium risk - implies sector-wide talent crunch or trial failures prompting churn, watch for pipeline impacts
- Consumer Staples/Discretionary Opacity◆
8 firms (Newell Brands, Bloomin' Brands, e.l.f Beauty, Texas Roadhouse, Hormel, Pool Corp, Kontoor Brands, Saga Comm) avg low-medium risk 4.4/10 materiality; non-disclosure pattern vs. no revenue/margin trends risks hidden demand weakness
- Financials Governance Watch◆
5 filings (Goldman Sachs, Live Oak Bancshares, BayFirst Financial, American States Water, unknown #8?) avg materiality 5/10 medium risk; lack of insider/ration details amid rate environment signals potential NIM pressure tie-in
- Auto/Transport Churn◆
5 firms (Sonic Automotive, Lithia Motors, Knight-Swift, Genco Shipping, Delta Air Lines) clustered changes no metrics disclosed, medium risk avg; EV transition or supply chain strains may drive exec shifts
- Pervasive Non-Disclosure◆
49/49 filings lack position/reason/quant data (no YoY trends, insider trades, guidance), 41% medium risk - portfolio-level transparency erosion vs. peers, bearish for governance-sensitive funds
- Large-Cap Resilience◆
Mega names (Northrop 3/10 low risk, Goldman 6/10, Delta 4/10, Hormel 6/10) lower avg risk than small-caps, suggests planned rotations over crises
Watch List(8)
Highest 7/10 materiality, monitor follow-on 8-K for CEO/CFO specifics + comp terms, potential Q1 catalyst Feb-Mar 2026
Item 2.05 exit costs + 5.02 change, watch earnings call for cost quantification and leadership rationale ~late Feb 2026
Medium risk financial giant, track news/insider filings for position (e.g., trading head?) impact on Q1 guidance
- Biotech Cluster (9 firms)/Follow-ons👁
Aggregate watch for appointment announcements revealing sector trend (instability vs. refresh), next 7-14 days
Item 7.01 tied to change, monitor for forward guidance update on RV volumes/margins post-filing
Amendment flags evolving story, watch for full details on compensatory arrangements affecting retention
6/10 materiality tech play, exhibits may reveal insider holdings changes, check Form 4s immediately
Items 5.02+7.01+8.01 combo, track for Macau/Asia ops tie-in via upcoming investor call
Filing Analyses(49)
13-02-2026
Newell Brands Inc. filed a Form 8-K on 2026-02-13 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
13-02-2026
ALLIANCE ENTERTAINMENT HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006492), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, position, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.
13-02-2026
Bloomin' Brands, Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer's name, position, reason for change, or timing are disclosed.
13-02-2026
Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.
13-02-2026
LCI Industries filed an 8-K on February 13, 2026 (AccNo: 0000763744-26-000004, size 705 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.
- ·Event date: February 13, 2026
- ·Source: us_sec
- ·Sector: not specified
13-02-2026
LAS VEGAS SANDS CORP filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. Sector is not specified.
13-02-2026
GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.
13-02-2026
The company filed an 8-K on February 13, 2026 (AccNo: 0001331754-26-000028), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or effective date beyond the filing date are provided. No quantitative data, financial metrics, or additional context such as board impacts or succession planning is disclosed.
13-02-2026
SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or other outcomes are mentioned.
13-02-2026
Graco Inc filed a Form 8-K on February 13, 2026 (AccNo: 0000042888-26-000036, size 141 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, reasons for the change, effective dates, or any quantitative terms are explicitly stated. This represents a standard officer change event with sector not specified and no associated financial metrics or performance comparisons provided.
- ·AccNo: 0000042888-26-000036
- ·Event Type: Officer Change
- ·Source: us_sec
13-02-2026
Mag Magna Corp filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. Sector information is not specified.
13-02-2026
POOL CORP filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051351), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including affected positions, names, reasons for the change, internal/external status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
13-02-2026
FOX FACTORY HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001424929-26-000004), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on affected positions, individuals involved, reasons for change, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
13-02-2026
BiomX Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
13-02-2026
LendingTree, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are disclosed. No financial metrics, quantitative data, or other outcomes such as board decisions are mentioned.
13-02-2026
e.l.f. Beauty, Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individuals involved, reason for change, or any financial impacts are provided. No quantitative metrics, performance data, or scheduled events mentioned.
13-02-2026
Texas Roadhouse, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
13-02-2026
Offerpad Solutions Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051334), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.
13-02-2026
Kestrel Group Ltd filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008071), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual names, appointment/resignation status, reasons, or impacts are disclosed.
13-02-2026
SpyGlass Pharma, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are provided in the available information. No positive or negative impacts, quantitative data, or further context such as board composition changes are disclosed.
13-02-2026
Centessa Pharmaceuticals plc filed an 8-K on 2026-02-13 (AccNo: 0001193125-26-051424, Size: 189 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any financial metrics are disclosed. No positive or negative governance implications can be assessed due to lack of details.
- ·AccNo: 0001193125-26-051424
- ·Filing size: 189 KB
- ·Sector: not specified
13-02-2026
PLUS Therapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051379) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or terms are disclosed. No quantitative metrics, financial impacts, or other changes are mentioned.
13-02-2026
Apple Hospitality REIT, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or timing are provided in the filing summary. No quantitative data, performance metrics, or further governance implications are disclosed.
13-02-2026
SAGA COMMUNICATIONS INC filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, reason for change, timing, or any quantitative metrics are disclosed.
13-02-2026
Data Storage Corp filed an 8-K on February 13, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are disclosed.
13-02-2026
QuidelOrtho Corp filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051461), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer, position, reason for change, or timing are disclosed. Sector is not specified.
- ·Filing size: 130 KB
13-02-2026
Werewolf Therapeutics, Inc. filed an 8-K on February 13, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, officer or director changes including departures, elections, appointments, or compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. No specific details on personnel changes, reasons, costs, or financial impacts are disclosed. This combination signals potential restructuring but lacks quantification for assessment.
13-02-2026
NORTHROP GRUMMAN CORP /DE/ filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008140), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, action (appointment or resignation), reason, effective date, or any quantitative data are disclosed.
- ·Event Type: Officer Change
- ·Source: us_sec
- ·Sector: not specified
- ·Filing Size: 190 KB
13-02-2026
Knight-Swift Transportation Holdings Inc. filed an 8-K on February 13, 2026 (AccNo: 0001492691-26-000012), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or scheduled events mentioned.
13-02-2026
Lithia Motors Inc filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with Item 9.01 for Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other changes are mentioned.
13-02-2026
Hormel Foods Corp /DE/ filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included, but specific details such as names, titles, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
13-02-2026
Peraso Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016466), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, or quantitative details are disclosed.
- ·File size: 189 KB
13-02-2026
International Tower Hill Mines Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015257), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided in the filing summary.
13-02-2026
Goldman Sachs Group Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are disclosed. No quantitative metrics, performance comparisons, or scheduled events are mentioned.
13-02-2026
AMERICAN STATES WATER CO filed a Form 8-K on February 13, 2026 (AccNo: 0001628280-26-008178), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are provided in the filing summary. No quantitative data, financial metrics, or further governance implications are disclosed.
13-02-2026
Longeveron Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
13-02-2026
Kontoor Brands, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001760965-26-000006), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment/resignation status, reasons, or any quantitative impacts are NOT_DISCLOSED.
13-02-2026
CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.
13-02-2026
NexMetals Mining Corp. filed an 8-K on 2026-02-13 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
13-02-2026
BayFirst Financial Corp. filed an 8-K on 2026-02-13 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the individuals involved, reasons for change, timing, or impacts are disclosed.
13-02-2026
Zenas BioPharma, Inc. filed an 8-K on 2026-02-13 disclosing officer changes under Item 5.02, including potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons for changes, financial metrics, or quantitative details are disclosed.
13-02-2026
UFP Technologies Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or financial metrics are disclosed.
13-02-2026
Timken Co filed an 8-K on February 13, 2026 (AccNo: 0000098362-26-000014) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, internal/external status, and any board composition impacts are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or governance implications are provided in the summary.
13-02-2026
IDEXX Laboratories Inc./DE filed an 8-K on February 13, 2026 (AccNo: 0000874716-26-000007, Size: 276 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, timing, or quantitative impacts are disclosed. This is a routine governance disclosure with no financial metrics or performance data provided.
13-02-2026
Actinium Pharmaceuticals, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or quantitative data are disclosed. Sector information is not specified.
13-02-2026
Orchestra BioMed Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015315), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, titles, reasons for changes, timing details, compensation amounts, or other quantitative metrics are disclosed. Sector information is not specified.
13-02-2026
Delta Air Lines, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001683168-26-001033), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts were provided. Sector not specified.
13-02-2026
Sensei Biotherapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051815), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 49 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings